What You Should Know:
AmerisourceBergen Corporation (NYSE: ABC), announced the rebranding of its name and stock ticker change to Cencora, Inc. (NYSE: COR).Under the new name Cencora, the company unifies its 46,000 employees – across…
Continue Reading
More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more difficult by…
Continue Reading
The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and complete a series…
Continue Reading
Specialty medications are often used to treat complex diseases, many times in life-saving situations. But the robust process to onboard a patient on a specialty medication highlights an urgent need to modernize healthcare technology,…
Continue Reading
Healthcare innovation in drug development intersects with a few critical trends: the rise of artificial intelligence (AI) applications in healthcare—particularly machine learning (ML) and predictive analytics; the need to reduce the costs associated with…
Continue Reading
The MedCity Moves Podcast is back with another episode. We discuss some of the executive appointments occurring in the healthcare sector over the past month — including new leaders at AHIP, GoodRx and Phoenix…
Continue Reading
What You Should Know: The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on…
Continue Reading
by Fred Pennic 06/26/2023 Leave a Comment
What You Should Know:
Oaktree Capital Management has closed its Life Sciences Lending Fund with a total capital commitment of $2.3B, representing the largest pool of capital ever raised…
Continue Reading
The continued maturation of decentralized clinical trials (DCTs) has given researchers the ability to securely collect real-world data on patients as they go about their daily routines. This broader access provides us with new,…
Continue Reading
The consensus is 2022 was a challenging year for digital health companies. Venture capital and other startup investment in the U.S. digital health sector plummeted to $15 billion from more than $29 billion in…
Continue Reading
